ONC
BeOne Medicines Ltd.Company Information
- Company Name
- BeOne Medicines Ltd.
- CIK
- CIK0001651308
- Category
- Large accelerated filer
- Ticker: Exchange
- ONC: Nasdaq, BEIGF: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ONC
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-28
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 708,951
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 34,066,845
- Shares outstanding
- 111,575,812
- Ownership
- 30.53%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 11.97%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 5,098 | 4,792 | 4,548 | 4,037 | 2,756 | 2,516 | 2,627 | 2,702 | 2,593 | 2,793 | 3,172 | 3,067 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | - | - | - | - | - | - | - | - | - | 0 | 3 | 107 | ||||||
| Accounts Receivable Net Current | 1,056 | 938 | 865 | 863 | 771 | 717 | 676 | 569 | 529 | 435 | 358 | 309 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | - | - | - | - | - | - | - | - | - | - | 11 | 12 | ||||||
| Inventory Net | 733 | 682 | 608 | 532 | 503 | 495 | 495 | 432 | 443 | 447 | 416 | 317 | ||||||
| Prepaid Expense And Other Assets Current | 329 | 190 | 213 | 233 | 281 | 168 | 193 | 209 | 274 | 232 | 257 | 242 | ||||||
| Assets Current | 7,216 | 6,601 | 6,234 | 5,664 | 4,310 | 3,896 | 3,992 | 3,912 | 3,839 | 3,908 | 4,203 | 4,054 | ||||||
| Property Plant And Equipment Net | 1,643 | 1,641 | 1,642 | 1,628 | 1,616 | 1,599 | 1,578 | 1,563 | 1,516 | 1,418 | 1,324 | 1,178 | ||||||
| Operating Lease Right Of Use Asset | 146 | 145 | 148 | 140 | 146 | 146 | 139 | 101 | 104 | 88 | 95 | 99 | ||||||
| Finite Lived Intangible Assets Net | 61 | 62 | 63 | 64 | 65 | 50 | 51 | 54 | 54 | 55 | 57 | 54 | ||||||
| Other Assets Noncurrent | 110 | 104 | 102 | 136 | 162 | 150 | 160 | 201 | 199 | 199 | 125 | 141 | ||||||
| Assets Noncurrent | 1,960 | 1,952 | 1,955 | 1,968 | 1,988 | 1,945 | 1,929 | 1,919 | 1,873 | 1,760 | 1,602 | 1,471 | ||||||
| Assets | 9,176 | 8,554 | 8,189 | 7,633 | 6,298 | 5,842 | 5,921 | 5,831 | 5,712 | 5,668 | 5,805 | 5,525 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 470 | 424 | 479 | 384 | 361 | 364 | 405 | 308 | 333 | 357 | 315 | 342 | ||||||
| Accrued Liabilities Current | 1,264 | 1,079 | 1,109 | 1,002 | 909 | 692 | 804 | 717 | 647 | 569 | 694 | 506 | ||||||
| Taxes Payable Current | 76 | 64 | 42 | 11 | 6 | 34 | 26 | 15 | 5 | 27 | 23 | 20 | ||||||
| Operating Lease Liability Current | 22 | 21 | 21 | 16 | 17 | 18 | 18 | 18 | 18 | 19 | 22 | 23 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Long Term Debt Current | - | - | - | 52 | - | - | - | - | - | - | - | - | ||||||
| Long Term Debt Current | 191 | 116 | 57 | - | 808 | 763 | 852 | 864 | 852 | 827 | 688 | 329 | ||||||
| Short Term Borrowings | - | 9 | - | 813 | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 2,119 | 1,812 | 1,829 | 2,368 | 2,210 | 1,984 | 2,215 | 2,025 | 1,939 | 1,882 | 1,810 | 1,283 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Loans Payable | - | - | - | 140 | - | - | - | - | - | - | - | - | ||||||
| Other Long Term Debt Noncurrent | - | - | - | 833 | - | - | - | - | - | - | - | - | ||||||
| Long Term Debt Noncurrent | 882 | 963 | 962 | - | 146 | 160 | 166 | 188 | 185 | 199 | 198 | 202 | ||||||
| Operating Lease Liability Noncurrent | 48 | 50 | 53 | 51 | 54 | 55 | 44 | 32 | 35 | 18 | 22 | 25 | ||||||
| Deferred Income Tax Liabilities Net | 57 | 56 | 53 | 47 | 44 | 43 | 42 | 16 | 16 | 16 | 16 | 16 | ||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Liabilities Noncurrent | 78 | 82 | 80 | 64 | 63 | 66 | 67 | 51 | 52 | 49 | 51 | 42 | ||||||
| Liabilities Noncurrent | 1,882 | 1,982 | 1,999 | 1,135 | 318 | 358 | 374 | 369 | 407 | 426 | 458 | 478 | ||||||
| Liabilities | 4,002 | 3,793 | 3,827 | 3,503 | 2,528 | 2,342 | 2,589 | 2,395 | 2,346 | 2,307 | 2,268 | 1,762 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 13,055 | 12,906 | 12,759 | 12,617 | 12,395 | 12,247 | 12,088 | 11,974 | 11,840 | 11,705 | 11,599 | 11,503 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -25 | -53 | -78 | -101 | -114 | -142 | -149 | -84 | -140 | -132 | -99 | -145 | ||||||
| Retained Earnings Accumulated Deficit | -7,856 | -8,093 | -8,320 | -8,386 | -8,511 | -8,606 | -8,607 | -8,455 | -8,334 | -8,213 | -7,962 | -7,594 | ||||||
| Stockholders Equity | 5,174 | 4,760 | 4,361 | 4,129 | 3,770 | 3,500 | 3,332 | 3,436 | 3,366 | 3,360 | 3,537 | 3,763 | ||||||
| Liabilities And Stockholders Equity | 9,176 | 8,554 | 8,189 | 7,633 | 6,298 | 5,842 | 5,921 | 5,831 | 5,712 | 5,668 | 5,805 | 5,525 | ||||||
Common Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | - | - | - | - | - | 731 | 731 | 731 | 731 | 731 | 731 | 731 | ||||||
| Common Stock Shares Issued | 119 | 119 | 119 | 119 | 119 | 108 | 107 | 107 | 106 | 105 | 105 | 104 | ||||||
| Shares Outstanding | 113 | 111 | 111 | 111 | 110 | 108 | 107 | 107 | 106 | 105 | 105 | 104 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBeOne Medicines Ltd. (ONC) — SEC Financial Statements & Analysis
BeOne Medicines Ltd. (ONC) is a pharmaceutical preparations company. BeOne Medicines Ltd. trades on Nasdaq, OTC as: ONC, BEIGF. BeOne Medicines Ltd. (ONC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, BeOne Medicines Ltd. carries a market cap of $31.80B, a P/E ratio of 48.49x, a P/B ratio of 6.15x, a P/S ratio of 5.19x, an enterprise value of $27.59B, and an EV/EBITDA multiple of 25.59x. On profitability, it posts a gross margin of 88.89%, an operating margin of 15.06%, a net margin of 10.70%, a Return on Equity (ROE) of 14.66%, a Return on Assets (ROA) of 8.47%, and a Return on Invested Capital (ROIC) of 44.71%. Per share, it reports EPS of $5.88, diluted EPS of $5.66, free cash flow per share of $11.92, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 34.35% year-over-year, net income growth of -469.12% year-over-year, and EPS growth of -458.35% year-over-year. On the balance sheet, it maintains a current ratio of 3.40x, a quick ratio of 2.90x, working capital of $5.10B, a debt-to-equity ratio of 0.77x, a debt ratio of 0.44, an interest coverage ratio of 12.20x, free cash flow of $1.33B (TTM), and net debt of $-4.21B. Figures sourced from SEC EDGAR.
- Market Cap
- $31.80B
- P/E TTM
- 48.49x
- EPS TTM
- $5.88
- P/B TTM
- 6.15x
- ROE TTM
- 14.66%
- ROA TTM
- 8.47%
- Debt To Equity
- 0.77x
- Free Cash Flow TTM
- $1.33B
- Net Revenue TTM Growth 1Y
- 34.35%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BeOne Medicines Ltd. in?
BeOne Medicines Ltd. (ONC) operates in the Pharmaceutical Preparations industry.
What exchange does ONC trade on?
BeOne Medicines Ltd. (ONC) trades on the Nasdaq, OTC.
When was BeOne Medicines Ltd. (ONC)'s most recent SEC filing?
BeOne Medicines Ltd. (ONC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is ONC's market cap?
BeOne Medicines Ltd. (ONC) has a market capitalization of $31.80B as of 2026-06-30.
What is ONC's P/E ratio?
BeOne Medicines Ltd. (ONC)'s trailing twelve month P/E ratio is 48.49x as of 2026-06-30.
What is ONC's EPS (earnings per share)?
BeOne Medicines Ltd. (ONC)'s trailing twelve month EPS is $5.88 as of 2026-06-30.
What is ONC's ROE (return on equity)?
BeOne Medicines Ltd. (ONC)'s trailing twelve month Return on Equity (ROE) is 14.66% as of 2026-06-30.
What is ONC's ROA (return on assets)?
BeOne Medicines Ltd. (ONC)'s trailing twelve month Return on Assets (ROA) is 8.47% as of 2026-06-30.
What is ONC's ROIC (return on invested capital)?
BeOne Medicines Ltd. (ONC)'s trailing twelve month Return on Invested Capital (ROIC) is 44.71% as of 2026-06-30.
What is ONC's EV/EBITDA?
BeOne Medicines Ltd. (ONC)'s trailing twelve month EV/EBITDA is 25.59x as of 2026-06-30.